Pfizer Inc. buy Guggenheim
Start price
17.12.25
/
50%
€21.74
Target price
17.12.26
-
Performance (%)
0.71%
Price
09.01.26
€21.90
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by 0.71%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pfizer Inc. | 1.908% |
| iShares Core DAX® | 3.002% |
| iShares Nasdaq 100 | 2.966% |
| iShares Nikkei 225® | 5.606% |
| iShares S&P 500 | 2.312% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat